Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 15.50 +0.25 (1.64%)
Previous Close $15.25    52 Week High $30.40 
Open $15.33    52 Week Low $11.86 
Day High $16.12    P/E N/A 
Day Low $15.30    EPS $0.00 
Volume 3,620,039